Table 4.
Effect of Probiotics/Prebiotics Supplementation on Gut Microbiota Recovery Among HIV Patients
| AuthorRef. | Type of probiotics/prebiotics | Duration | Specimen type | Methods | Major finding |
|---|---|---|---|---|---|
| Villar-Garcia et al.10 | Saccharomyces boulardii | 12 Weeks | Stool and blood sample | 16S rDNA | After probiotics supplementation, Clostridiales species level decreased compared with the control group. |
| Deusch et al.50 | scGOS/lcFOS/glutamine | 6 Weeks | Stool sample | Shotgun proteomics 16S rDNA | Bifido bacteria increased in abundance in IR and VU (74-fold) patients after prebiotics intake. |
| d'Ettorre et al.57 | High concentration lyophilized multi-strain probiotic | 6 Months | Large and small intestine biopsy and blood sample | PCR, RPMI media | After 2 months of probiotics supplementation, Bifido bacteria spp. increased (p < .019) and it remained stable until the end of the study. |
| d'Ettorre et al.61 | Dietary supplement with probiotics | 48 Months | Blood sample | Minus One method (FMO) | Translocation markers, elevated hsCRP (45%–20%), and the percentage of CD4+ CD38+HLA-DR+ T cell (p < .001) show a significant reduction after probiotics consumption. |
| Scheri et al.62 | Probiotics preparations contain live bacteria | 6 Months | Blood and stool sample | QIAamp (PCR) | The serum level of CD4+CD38+HLA−DR+ T cells shows a statistically significant reduction at 6 months compared with time zero (p = .008), and Bifidobacteria spp. increased in all patients (p = .019) after probiotics. |
| Serrano-Villar et al.65 | scGOS/lcFOS/glutamine | 6 Weeks | Stool sample | 16S rRNA | T cell activation decreased in VU (p = .006) and INR groups (p = .04) concomitantly, and microbiota structure changed in β diversity analysis after probiotics intervention. |
FMO, fluorescence minus one method; hsCRP, high sensitivity C-reactive protein; PCR, polymerase chain reaction.